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Abstract
Background: Urogenital schistosomiasis is caused by the helminth parasite Schistosoma haematobium. In high transmission
areas, children acquire schistosome infection early in life with infection levels peaking in early childhood and subsequently
declining in late childhood. This age-related infection profile is thought to result from the gradual development of
protective acquired immunity. Age-related differences in schistosome-specific humoral and cellular responses have been
reported from several field studies. However there has not yet been a systematic study of the age-related changes in human
dendritic cells, the drivers of T cell polarisation.
Methods: Peripheral blood mononuclear cells were obtained from a cohort of 61 Zimbabwean aged 5–45 years with a S.
haematobium prevalence of 47.5%. Two subsets of dendritic cells, myeloid and plasmacytoid dentritic cells (mDCs and
pDCs), were analyzed by flow cytometry.
Findings: In this population, schistosome infection levels peaked in the youngest age group (5–9 years), and declined in late
childhood and adulthood (10+ years). The proportions of both mDCs and pDCs varied with age. However, for mDCs the age
profile depended on host infection status. In the youngest age group infected people had enhanced proportions of mDCs
as well as lower levels of HLA-DR on mDCs than un-infected people. In the older age groups (10–13 and 14–45 years)
infected people had lower proportions of mDCs compared to un-infected individuals, but no infection status-related
differences were observed in their levels of HLA-DR. Moreover mDC proportions correlated with levels of schistosome-
specific IgG, which can be associated with protective immunity. In contrast proportions of pDCs varied with host age, but
not with infection status.
Conclusions: Our results show that dendritic cell proportions and activation in a human population living in schistosome-
endemic areas vary with host age reflecting differences in cumulative history of exposure to schistosome infection.
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Introduction
Schistosoma haematobium helminth parasites cause urogenital
schistosomiasis which affects about 112 million people mainly in
rural areas of subtropical countries [1]. Infections with S.
haematobium are most common in school-age children. Populations
in endemic areas show a characteristic age-infection profile with
infection levels increasing to peak in early to late childhood,
typically around 9–15 years and then declining in adulthood [2–
4]. This profile is believed to be largely reflective of the gradual
development of protective acquired immunity reducing re-
infection levels [2,5,6]. The consequence of this age profile is that
individuals with comparable infection levels who have resided in a
schistosome endemic area since birth (e.g. egg negative children
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versus egg negative adults) can differ significantly in their immune
response against the parasite and thus their levels or resistance to
re-infection. Several studies characterizing human immune
responses to schistosome infections have shown age related
differences in antibody levels [7–9], plasma cytokines [10],
parasite-specific cytokines [11] and regulatory T cell proportions
[12]. This concept is supported by theoretical modelling of the
development of acquired immunity, which predicts that correla-
tions between immunological responses and infection is positive in
younger age groups and subsequently decreasing and potentially
turning in a negative correlation [13]. Moreover this pattern is not
restricted to schistosome infections, but is a characteristic of
immune responses associated with protection from a variety of
helminth species in endemically-exposed populations [14,15].
As investigations of the nature and development of protective
acquired immunity progress, there has been a move to decipher
the mechanisms and pathways behind these observed age-related
patterns. Human field studies show that the immune response
against schistosomes is characterized by a very complex interaction
of TH1, TH2 and regulatory responses [10–12,16–18] with
differences between natural human infections and experimental
mouse models [19,20]. Nevertheless, the induction of a TH2
response is important in the immune response against schistosomes
[21] and in particular for the development of protection [22]. As a
major antigen-presenting cell population dendritic cells (DCs) are
responsible for acquiring, processing and presenting parasite
antigens to T cells and the latter interaction leads to activation
and polarisation of the acquired immune response. The impor-
tance of DCs in the induction of the TH2 immune responses in the
context of schistosome infections has been recently highlighted in
an experimental mouse model [23]. This study indicates that DCs
are required for the induction and development of TH2 responses
during schistosome infections supporting other studies showing the
importance of DCs in the context of TH2 induction [24–27].
It has been shown that schistosome derived compounds can
activate dendritic cells by toll-like receptors (TLR)-2 and 3 [28,29]
and early TH2-promoing activities can be diminished by TLR-3
[30]. Overall studies are rare addressing the role of the innate
immune cells in the immune response against schistosomes [31].
In particular, studies analysing DCs directly from humans
exposed to schistosomes are limited. The first study addressing this
question, published by Everts and colleagues in 2010, elegantly
showed changes in DCs during chronic schistosomiasis (S.
haematobium) [32] suggesting that chronic schistosomiasis can
suppress DCs, which might play a role in immune modulation
by schistosomes.
Peripheral blood DCs can be divided in two major subsets
[33,34], myeloid dendritic cells (mDC; or conventional DC) and
plasmacytoid (pDC). Myeloid DCs express CD11c, but low levels
of CD123 and have a more pronounced role in antigen processing
and initiation of T cell response [35]. Plasmacytoid DCs express
CD303 (BDCA-2), ILT7, high levels of CD123 (IL-3Ra), but are
negative for the classical marker CD11c [33,36–38]. These pDCs
play a critical role in anti-viral immunity as well as in immune
tolerance [39,40]. Everts et al’s [32] study focusing on people aged
17–39 years showed that the frequencies of mDCs and pDCs are
reduced in infected people compared to un-infected and that
mDCs are functionally impaired in response to toll-like receptor
ligands and in driving T cell responses ex vivo. Since in most
schistosome endemic areas people are exposed to infection from as
young as 6 months old [41], and may already be carrying heavy
infections within the first decade of life [8], these early infection
events may have a profound effect on the proportions of the DCs
present in the host. Characterising the role of these cells during
natural immune responses to helminth infection in the different
age groups is vital for vaccine development, since people targeted
by anti-schistosome vaccines in endemic areas will have been
previously exposed to infection and their cellular immune
responses will already be primed by repeated exposure to parasite
antigens. In this context variations in antigen presenting cell
populations, including DCs, might directly affect the efficacy of
vaccination in different age groups. Lessons from the discontinued
human hookworm vaccine trials, illustrate the importance of
characterising existing natural immune responses in endemic
populations and designing vaccine to avoid undesirable patholog-
ical outcomes of vaccination [42]. Therefore, the aim of this study
was to characterise the relationship between age and DCs during
natural schistosome infections and determine if these patterns are
affected by host infection status across different age groups
reflecting different dynamics in the acquisition and loss of
schistosome infection.
Methods
Study population and parasitology
This study was performed in Chipinda village which is located
in the Mashonaland East Province in Zimbabwe (31u949E;
17u679S). The village was selected because health surveys regularly
conducted in the region showed little or no infection with soil-
transmitted helminths (STH) and a low S. mansoni prevalence
(,2%), which elicit immune responses that cross-react with those
against S. haematobium [43,44,45]. The low STH and S. mansoni
prevalence is consistent with earlier surveys in this area of
Zimbabwe [46–48]. Villagers are subsistence farmers who have
frequent contact with water sources posing a risk of infection (as
assessed by questionnaires) due to insufficient safe water provision
and low coverage of sanitation facilities as is typical in rural
Zimbabwe. Drinking water is collected from open wells while
bathing and washing is conducted in perennial rivers surrounding
the village. This area has not been included in any Schistosome
Author Summary
A characteristic feature of most helminth infections is the
convex age infection profile, where infection levels rise to
peak in early childhood and decline in adulthood, a
pattern thought to result from the development of
protective acquired immunity. Thus, several investigations
characterizing protective responses to inform vaccine
research have focused on responses present in older
people, who despite continued exposure to infection carry
little or no infection. To date, such studies have identified
key responses which are correlates of resistance. However,
there is a paucity of information on cell types that are
mediators rather than effectors of the immune responses.
One such group where there are limited studies in human
schistosome infections is dendritic cells which are impor-
tant for the polarizations of CD4+ T cell responses.
Therefore, we characterized the age profile of dendritic
cells in Zimbabweans exposed to Schistosoma haemato-
bium infection. We found an age-related pattern in the
proportions of myeloid dendritic cells (a subset of
dendritic cells) in this population. Furthermore, in the case
myeloid dendritic cells, the age profile differed between
schistosome infected and un-infected people. Thus our
study suggests that activation and migration of myeloid
dendritic cells also develop in an age-related pattern
consistent with the cumulative history of exposure to
schistosome parasites.
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Control Programmes and therefore participants had not received
any anti-helminthic treatment for schistosomiasis or other
helminth infections prior to this study. Thus their natural immune
responses could be assessed in the absence of drug-altered
schistosome-specific responses [49,50]. Urine and stool samples
were collected on three consecutive days and examined micro-
scopically for S. haematobium (urine filtration, Mott method [51]) or
S. mansoni and intestinal helminths (Kato-Katz method [52])
respectively using standard procedures. Participants were screened
for malaria by microscopic examination of Giemsa stained blood
smears and HIV status was determined by immunochromato-
graphy (DoubleCheckGoldTM HIV 1&2, Orgenics) with HIV
positive samples subsequently re-tested by a second rapid assay
(Determine HIV 1/2 Ag/Ab Combo, InvernessMedical) to
confirm HIV status [53]. Study participants had to meet the
following criteria: (1) be life-long residents in this area (assessed by
questionnaires) so that age would be a proxy for duration of
exposure to S. haematobium infection, (2) should not have received
anti-helminthic treatment prior to this study, (3) should have
provided at least two urine and two stool samples on consecutive
days for parasitological diagnosis, (4) should have tested negative
for intestinal helminths including S. mansoni to focus on single
infections with S. haematobium, (5) should be negative for HIV and
malaria (Prevalence of both HIV and malaria were too small for
inclusion in the statistical analysis (HIV prevalence in Chipinda
village was 8% and no-one was positive for malaria infection at the
time of sampling) and (6) have provided a sufficient volume of
blood to isolate peripheral blood mononuclear cells (PBMC). The
selected cohort comprised 61 individuals and details to the cohort
are provided in Table 1.
Ethical statement
Permission to conduct the study in the region was obtained from
the Provincial Medical Director and institutional and ethical
approval was received from the University of Zimbabwe’s Institute
Review Board and the Medical Research Council of Zimbabwe
respectively. Only compliant participants were recruited and they
were free to drop out at any point during the study. At the
beginning of the study, participants and their parents/guardians
(in case of children) had the aims and procedures of the project
explained fully in the local language, Shona, and written consent
was obtained from participants and parents/guardian before
parasitology and blood samples were obtained. After collection of
all samples, all participants were offered anti-helminthic treatment
with the recommended dose of praziquantel (40 mg/kg of body
weight).
Blood collection and isolation of PBMC
Depending on age of the participants up to 25 ml of venous
blood was collected in heparinized tubes of which approximately
5 ml was used for serological assays as well as microscopic
detection of malaria parasites. The remaining blood was used for
the isolation of peripheral blood mononuclear cells (PBMC)
through density gradient centrifugation using Lymphoprep (Axis-
Shield, Cambridgeshire, UK). These PBMC were subsequently
enumerated, cryo-preserved in 10% DMSO, 90% fetal calf serum
and stored in liquid nitrogen in Zimbabwe prior to shipping to
Edinburgh in dry shippers for assaying.
DC phenotyping
Thawing of cryo-preserved PBMC was performed by rotating
cryovials in a 37uC water bath until a small crystal was remaining
in the cell suspension. Cells were then slowly re-suspended in
RPMI 1640 supplemented with 10% FCS, 2 mM L-glutamine
and 100 U Penicillin/Streptomycin (all Lonza, Verviers, Belgium).
Cells were washed twice with media, counted and viability assessed
using trypan blue (Sigma-Aldrich, Dorsert, UK). The median
viability of the PBMCs was 71.4% which is within the range of
published values [54]. In addition it was confirmed that including
a viability marker did not change analysis of subsets. Afterwards,
cells were washed with Dulbecco’s-PBS (Lonza) and surface
stained with the following antibodies: Qdot-605-conjugated anti-
CD14 (clone TUK4, Invitrogen), FITC-conjugated anti-CD11c
(clone Bu15, Invitrogen), APC-H7-conjugated anti-HLA-DR
(clone L243, BD Biosciences), PE-Cy5. anti-CD123 (clone 9F5,
BD Biosciences) and V450 BD Horizon-conjugated anti-CD86
(clone 2331, BD Biosciences), PE-conjugated anti-BDCA-2 (clone
AC144, Miltenyi Biotec) and APC-conjugated anti-BDCA-4
(clone AD5-17F6, Miltenyi Biotec). Stained cells were acquired
on a FACSCantoII (BD Biosciences) and analyzed using FlowJo
software software (TreeStar, USA).
Antibody ELISAs
Serum antibody levels were measured by enzyme-linked
immunosorbent assays (ELISA) following established protocols
[8,55]. Whole worm homogenate (WWH) was obtained from the
Theodor Bilharz Research Institute (Giza, Egypt). In short,
microtiter plates were coated overnight at 4uC at 10 mg/ml.
Serum samples were diluted at 1:20 for WWH-IgE and 1:100 for
WWH-IgG and IgM and incubated for 2 hours at 37uC. Horse-
radish peroxide conjugated antibodies were diluted 1:1000 for
IgG, IgE and IgM and incubated for 1 hour at 37uC. ELISAs were
developed using ABTS (Southern Biotech) and stopped after
15 minutes for IgG and IgM, and 30 minutes for IgE. Absorbance
was read at 405 nm. Serum was available from 45 out of 61
individuals.
Table 1. Study population.
S. haematobium
Age group N mean age in years (range) Male/female Prevalence in % (95% CI) Mean egg count ± SEM (range)
Total 61 14.1 (5–45) 27/34 47.5 (35.6–59.9) 51.6619.3 (0–859)
Group 1 17 7.6 (5–9) 8/9 35.3 (15.9–54.8) 78.1651.4 (0–859)
Group 2 23 11.1 (10–13) 8/15 52.2 (36.0–68.5) 47.7625.9 (0–571)
Group 3 21 22.6 (14–45) 11/10 52.4 (35.0–69.9) 34.5626.0 (0–550)
SEM – Standard error of mean, CI – Confidence interval.
doi:10.1371/journal.pntd.0001824.t001
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Statistical analysis
The proportions of DC cell subsets were square root arcsine
transformed whereas expression levels of HLA-DR and CD86
were square root transformed to allow the use of parametric tests
in subsequent analyses [56]. To analyse which factors influence the
proportion of DC subsets, a univariate analysis of variance using
sex (male/female), host age groups (group 1: 5–9 years; group 2:
10–13 years; group 3: 14+ years) and infection status (un-
infected = 0 mean egg count per 10 ml and infected .0 mean
egg count per 10 ml; all variables categorical) as independent
variables was performed. The three different age groups were
selected to reflect epidemiological groupings (i.e. where infections
are acquired, peak and decline) by age and infection intensity and
to obtain comparable sample sizes between the groups. Post hoc
tests between infected and un-infected individuals were conducted
in each age group. In addition post hoc analysis was performed to
determine differences in pDCs between the three age groups. To
determine if the mDC populations showed an age profile
consistent with those for protective immune responses as predicted
by quantitative studies [13], correlation analyses between infection
intensity (log10 (mean egg count+1) transformed) and proportions
of mDCs was conducted after allowing for the effect of sex. The
correlation coefficients were then tested for homogeneity using the
Fisher’s r-to-z transformation [57]. Correlation analyses between
WWH-specific IgG and DC cell subsets were performed after
allowing for the effects of sex, age and infection intensity. All
statistical tests were conducted using the software package SPSS
v14 and p values were taken to be significant at p,0.05.
Results
Epidemiology of study population
This study was designed to focus on the immune modulation in
a population exposed to S. haematobium. The northeast part of
Zimbabwe is endemic for S. haematobium with many regions having
a moderate to high prevalence of S. haematobium, but low
prevalence of S. mansoni and soil-transmitted helminths [47,48].
The overall prevalence in Chipinda was (39%). This is defined by
the World Health Organisation (WHO) as a moderate transmis-
sion area [58]. The overall prevalence of S. haematobium in the
selected study population (N= 61) was 47.5% which is higher but
not significantly different from (x2 = 1.688, df = 1, p = 0.097) the
village prevalence of 39% and still within the WHO definition of
moderate transmission. The difference in infection prevalence
between the youngest age group (35.3%) compared to more than
50% in the older age groups was not significant (x2 = 0.806, df = 1,
p = 0.185; details in Table 1). However, youngest individuals (5–9
years) who were infected carried high infection levels (Figure 1 and
Table 1). Individuals aged 10–13 years still showed high infection
levels, but with a higher prevalence than the first age group. In
contrast, in the oldest age group (14–45 years), the prevalence
remained high, but most individuals show lower infection
intensities (Figure 1). The consequence of the infection profile is
that individuals who are life long residents in the area and have
never received treatment with anti-helminthic drugs (see selection
criteria in Methods) differ in their cumulative histories of exposure
despite carrying comparable infection intensities. This was
supported by an analysis of the serum levels of adult worm
specific (whole worm homogenate – WWH) antibody levels. As
shown in Figure 2A and B levels of WWH-specific IgE and IgG,
which are associated with history of infection and resistance to
infection [59–61], increase significantly with age. In contrast IgM
against WWH as marker of current infection starts to decrease in
the oldest age group (Figure 2C).
Characterization of mDCs and pDCs in total study
population
To analyze mDCs and pDCs, PBMCwere gated on CD14negHLA-
DR+ cells (Figure 3A, B). Gated cells were stained with CD123 and
CD11c to distinguish mDCs (CD11c+CD123neg/low) from pDCs
(CD123hiCD11cneg; Figure 3C). To further verify specificity of pDC
gated CD123hiCD11cneg were analysed for the expression of BDAC-
2/CD303 and BDCA-4/CD304 [62] and granularity of gated cells
was analysed in an FSC/SSC plot (Figure 3D). Therefore other cell
types such as basophiles or B cell potentially able to express CD123 are
excluded from the analysis. mDC did not express either BDCA-2 or
BDCA-4 (Figure 3E). Subsets were expressed as percentages of PBMC
or as percentage of CD14negHLA-DR+ cells. Both subsets were
subsequently analysed for the expression of CD86 (Figure 3D, E) and
levels of HLA-DR within the two different DC populations as
indicators of DC activation status and their ability to present antigen
and co-stimulatory signals to T cells.
When the study population was portioned by infection status (un-
infected versus infected), neither mDCs (Figure 4A) nor pDCs
(Figure 4B) showed a significant difference between both popula-
tions. Comparable results were obtained if DC subsets were
expressed as percentage of CD14negHLA-DR+ (data not shown).
Myeloid DCs showed a significant association with sex (Table 2), in
which female had slightly higher proportions than males. This was
then statistically accounted for in all subsequent analyses.
Age dependent pattern of mDCs and pDCs
The age in the total population ranged from 5–45 years. Age
group significantly affected the proportions of pDCs (Table 2),
Figure 1. Age – infection profile of the study population. The
study population was divided into three age groups: 5–9 years (N= 17),
10–13 years (N = 23) and 14+ years (N = 21). Mean infection intensities
from at least two urine samples for each individual are given. The mean
for each group is indicated.
doi:10.1371/journal.pntd.0001824.g001
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with a significant increase between 5–9 year olds (age group 1) and
14+ year olds (age group 3; p = 0.033). In contrast for mDCs the
relationship with age varied depending on infection status
(significant interaction between age group and infection status;
Table 2). Based on these results post hoc analysis of mDC
proportions by infection status was performed after partitioning
the study population into the three different age groups (details in
Table 1). In the youngest age group (Figure 5A) infected people
had significantly higher mDC percentages than un-infected
people. Results were comparable if expressed as percentage of
CD14negHLA-DR+ (Figure S1A). This pattern differed in the
second age group, where infected individuals showed fewer mDCs
than un-infected individuals (Figure 5B) a difference which was
even more pronounced in the oldest age groups (Figure 5C). A
comparable analysis could be made by correlating infection
intensity (rather than infection status) to percentages of mDCs in
the three different age groups. In the youngest age group both
parameters were positively correlated (b = 0.707, p = 0.001),
whereas in the second age group the correlation was instead
negative (b =20.441, p= 0.018). This negative correlation was
more pronounced in the third group (b =20.540, p = 0.007;
Figure 6). A test for the homogeneity of the correlations
coefficients showed a significant difference between age group
one and two (z = 3.89, p= 0.0001) and between the first and the
third age group (z = 4.17, p,0.0001).
In contrast, to the clear picture in the case of mDCs, there was
no significant difference in the proportion of pDCs (expressed
either relative to live PBMC or CD14negHLA-DR+) between un-
infected and infected people in any of the three age groups as
shown in Figure 7, Figure S1B and Table 2.
Expression of CD86 and HLA-DR on mDCs and pDCs
Up-regulation of CD86 is hallmark of maturation and activation
of DCs and their ability to provide co-stimulatory signals to T cells.
HLA-DR expression can be used as an indicator both of DC
activation status and their potential to activate antigen-specific T
cells. Neither infection status nor the interaction between infection
status and age group influenced expression of CD86 on mDC as
determined by ANOVA (Table 2), which was confirmed by post
hoc tests comparing CD86 expression between un-infected and
infected people after partitioning into age group (Figure 8A).
However HLA-DR expression was significantly influenced by an
interaction of age group and infection status (Table 2). Post hoc
test showed that HLA-DR expression differed between un-infected
and infected individuals, in the youngest age group. In this age
group HLA-DR was significantly lower on mDCs from infected
people compared to un-infected (Figure 8B). In contrast no
difference was observed in HLA-DR expression in people 10–13
years of age or in the oldest age group. Neither CD86 nor HLA-
DR expression on pDCs were dependent on age group, infection
status or the interaction of these variables (Table 2).
Interaction between mDCs and WWH-IgE
Adult worm specific IgG can be used as a marker development
of resistance against infection [59–61]. WWH-specific IgG
increases with age and in our population especially between the
first and second age group (Figure 2B) and to the same time
changes in mDC proportions between un-infected and infected
individuals occurred. Therefore the interaction between mDC and
WWH-specific IgG was analysed. As indicated in Table S1,
WWH-specific IgG is influenced by sex, age and infection
intensity, but addition also by proportions of mDC. mDC are
directly correlated to WWH-specific IgG after allowing for the
effects of sex, age and infection (Figure 9A). Although showing the
same tendency pDCs and WWH-specific IgG were not signifi-
cantly correlated (Figure 9B). This correlation was most obvious in
the oldest age group (Table S2) and overall more significant in un-
infected (protected) individuals. Correlation between mDC pro-
portions and WWH-specific IgE and IgM were not significant.
Discussion
Urogenital schistosomiasis caused by S. haematobium shows a
characteristic age-infection profile with increasing infections
intensities during early childhood, peaking usually between the
age of 9–15 years and than slowly declining towards adulthood [2–
Figure 2. Schistosome-specific antibody profiles. Serum levels of WWH-specific IgE (A), IgG (B) and IgM (C) were analysed by ELISA. Obtained
data are presented after diving into the three indicated age groups. Correlation coefficient b and significant values are indicated. The effect of sex has
been statistically allowed for.
doi:10.1371/journal.pntd.0001824.g002
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4]. This study investigated whether the age-related changes in
schistosome infection pattern impacted on the proportions and
phenotype of DCs.
We provide evidence that indeed there is an age-related pattern
in the proportions of mDCs, if infected and un-infected people
were compared. The proportion of mDCs were found to be
present in significantly higher proportions in infected individuals
compared to un-infected individuals in the youngest age group
carrying heaviest infection levels. This subsequently changes in
older age groups, were older infected individuals had lower
relative numbers of mDCs compared to un-infected people. The
gradual change between the three age groups became more
apparent when the correlation between infection intensity (rather
than infection status) and mDCs proportions were considered. In
this case both parameters were positively correlated in the
youngest age group and became a negative correlation with
increasing age. This pattern is consistent with that predicted by
quantitative studies for protective immune responses and has
already been demonstrated for antibody responses associated with
protection to re/infection in human hookworm [63] and
schistosome infections [64]. Importantly levels of adult worm
specific IgG are correlated with proportions of mDCs. This effect
was more significant in the oldest age group, in which protective
immunity becomes effective.
Our data confirm some of the major findings of a previous study
of DC populations in human schistosomiasis conducted by Everts
et al [32]. Proportions of mDCs were lower in an age group 14–45
years (mean 22.6 years) which is comparable to the population
studied by Everts et al (17–39 years). Since cellular immune
responses might depend on many different parameters such as
transmission dynamics or genetic background of the investigated
study population the consistency in DC proportions in schisto-
some-exposed human between our study and that by Everts et al,
by itself is an important finding. A major difference between the
two studies is that we did not observe differences in pDC
percentages in regards to infection status, although we had high
variation in pDC levels in the oldest age group. In deed a slight
tendency of lower pDC proportions (expressed as percentage of
PBMC) was observed in this age group. Differences in co-
infections may also account for the differences between our
observations and those of Everts et al [32] in Gabon. While the
population in Zimbabwe had no co-infection with other helminths,
Figure 3. Phenotyping DCs. Live PBMCs (A) are gated on CD14negHLA-DR+ cells (B) which subsequently are analysed for the expression of CD11c
and CD123 (C). CD123+CD11cneg (D) and CD123neg/lowCD11c+ (E) were subsequently analysed for the expression levels of BDCA-2/CD303 and BDCA-
4/CD304, CD86 and HLA-DR. Presented plots are an example and derived from a 5 year old female individual.
doi:10.1371/journal.pntd.0001824.g003
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Plasmodium or HIV, that in Gabon had co-infections with
microfilaria observed in 48% of the schistosome infected
individuals which could affect the pDCs proportions.
Both our study and that of Everts et al [32] clearly indicate the
difference in mDC populations between infected and un-infected
adults. However, since infections in moderate to high transmission
areas occur at relatively young age, we were interested in the
dynamics of the DCs over time, which was not possible in Evert’s
study. We wanted to determine when if at all the difference
between infected and un-infected people was established. There-
fore, we analysed DC cell populations in younger age groups. Our
study demonstrates that a lower frequency of mDCs in infected
people can be already observed in 10–13 year olds. This is
accordance with changes in other immunological parameters as
clearly shown for schistosome-specific IgG, IgE and IgM. The
importance of DC in TH2 induction has been recently shown [23].
By altering cytokine responses DC could finally be involved in
isotype switching and development of protective immunity. This is
supported by our finding of the correlation between schisotosome-
specific IgG and mDCs.
Changes with age have been also observed for serum cytokines
in other study populations with moderate/high schistosome
transmission [10,11,64]. For instance, high levels of parasite-
specific or serum levels of IL-10 have been reported already at this
age in different populations [11,65] and might contribute to such
changes. For example, DCs treated with the regulatory cytokine
IL-10 inhibit T cell activation [66–69]. Earlier studies showed that
T cell hypo-responsiveness can be already observed at early ages
Figure 4. Proportions of DCs in the study population. PBMC (N= 61) were analysed for proportions of (A) CD123neg/lowCD11c+ mDCs or (B)
CD123hiCD11cneg pDCs (expressed as % of PBMC). Data of the total population were divided in un-infected (N= 32, white box) and infected
individuals (N = 29, gray box). Data are presented as Whiskers boxplot (10–90 percentiles). Differences were analysed by univariate analysis after
accounting for the effect of sex.
doi:10.1371/journal.pntd.0001824.g004
Table 2. Effects of sex, age group and infection status on mDC and pDC proportions and levels of HLA-DR, CD86 expression on
both subsets.
Dependent variable Proportions of DCs HLA-DR expression CD86 expression
DC population Explanatory variable df F – value p – value df F – value p – value df F – value p – value
mDC sex 1, 60 4.659 0.35 1, 60 2.049 0.158 1, 60 0.297 0.588
age group 2, 60 0.646 0.528 2, 60 0.068 0.934 2, 60 0.064 0.938
infection status 1, 60 3.392 0.071 1, 60 0.372 0.544 1, 60 0.424 0.518
Age group * infection status 2, 60 11.963 ,0.001 2, 60 3.865 0.027 2, 60 0.763 0.471
pDC sex 1, 60 2.509 0.119 1, 60 2.240 0.140 1, 60 0.015 0.902
age group 2, 60 3.544 0.036 2, 60 0.075 0.928 2, 60 0.092 0.912
infection status 1, 60 1.237 0.271 1, 60 0.842 0.363 1, 60 1.184 0.281
Age group * infection status 2, 60 0.074 0.929 2, 60 1.246 0.296 2, 60 1.267 0.290
Results from univariate analyses of variance determining the effect of host sex, age group and infection status. Variables with significant influence are highlighted in
bold. df –degree of freedom. For mDCs and pDCs proportions of PBMC were analysed, whereas the MFI was used for HLA-DR and CD86 expression.
doi:10.1371/journal.pntd.0001824.t002
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[70,71]. The role of mDCs in induction of this impairment
remains to be further investigated.
Other reasons for reduced relative numbers of mDCs in
infected individuals in older age groups remain to be determined,
e.g. enhanced apoptosis, reduced bone marrow output or
increased migration to inflamed tissues or lymphoid organs were
proposed by Everts et al [32]. Indeed enhanced migration in the
context of TH2 priming DCs has been reported [25,72]. This was
induced by eosinophil-derived neurotoxin; a molecule elevated in
serum of S. haematobium infected people [73]. Everts et al reported a
more general impairment of DCs affecting both TH1 and TH2
cytokines as well as IL-10 in older individuals (17–39 years). The
mechanisms involved are still unclear since despite this impair-
ment of DC function, older individuals carrying schistosome
infection can show enhanced immunopathology [74,75] indicating
an effective immune response.
In contrast, our data show that in the younger individuals (5–9
years) mDCs proportions were higher in peripheral blood of
infected individuals in comparison to un-infected. Potential
reasons for this include enhanced bone marrow output or reduced
migration of DCs in the context of blood-born antigens [76].
Infection levels were highest in the youngest age group of our
Figure 5. Proportions of mDCs in different age groups. The study population was divided into three age groups: 5–9 years (A), 10–13 years (B)
and 14+ years (C). Proportions of mDCs were compared between un-infected (white box) and infected (gray box) individuals and expressed as %
percentage of PBMC. Differences between un-infected and infected groups in the different age groups were analysed by univariate analysis after
accounting for the effect of sex.
doi:10.1371/journal.pntd.0001824.g005
Figure 6. Correlation between infection intensity and mDCs. The study population was divided into three age groups: 5–9 years (left panel),
10–13 years (middle panel) and 14+ years (right panel). Proportions of mDCs expressed as % of PBMC are plotted against infection intensity (log10
(mean egg count+1) transformed). Correlation coefficient b and significant values of a correlation analysis after allowing for the effect of sex are
indicated.
doi:10.1371/journal.pntd.0001824.g006
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study population and young people might have more blood
migrating schistosome stages affecting proportions of circulating
mDCs. In contrast enhanced immune response including
enhanced migration of mDCs might lead to increased killing of
infiltrating schistosomula in older age groups.
Dendritic cell activation/maturation is characterised by up-
regulation of cell-surface markers such as CD86 and MHC
class II molecules. As previously reported by Everts et al [32],
we observed no changes in expression of CD86 in infected
people. However HLA-DR levels differed. In the youngest age
group (5–9 years), where we found higher percentages of
mDCs, expression levels of HLA-DR were lower in infected
people. Reduced HLA-DR expression might be an indication
of less matured and possibly fewer migrating cells, which
subsequently could result in a less pronounced induction of T
cell response in an early phase of exposure to schistosomes
Figure 7. Proportions of pDCs in different age groups. The study population was divided into three age groups: 5–9 years (A), 10–13 years (B)
and 14+ years (C). Proportions of mDCs were compared between un-infected (white box) and infected (gray box) individuals and expressed as
percentage of PBMC (B). Differences between un-infected and infected groups in the different age groups were analysed by univariate analysis after
accounting for the effect of sex.
doi:10.1371/journal.pntd.0001824.g007
Figure 8. Expression levels of CD86 and HLA-DR on mDCs. PBMC were gated on mDCs as indicated in Figure 2 and analysed for the
expression of CD86 (A) and HLA-DR (B). Data partitioned into three age groups as indicated and compared between un-infected (white columns) and
infected individuals (gray columns).
doi:10.1371/journal.pntd.0001824.g008
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accompanied by a more regulatory environment due to Tregs
and parasite-specific IL-10 [11,12,65]. Analysis of Tregs from
another study cohort from the same population revealed a
comparable pattern as recently published by our group [12]. In
addition a direct comparison of mDCs and Tregs would need a
larger sample size, since statistical power is lost by comparing
the two parameters in the presence of other potentially
confounding variables such as host age.
In contrast to the study by Everts et al, we did not observe a
significant difference of HLA-DR levels in the older age groups.
Again more significant changes of HLA-DR in these age groups
might be due to cumulative effect of co-infections, not present in
our study population.
Inhibition of up-regulation of activation markers such as CD86 has
been suggested to be involved in induction of tolerogenic DCs [66].
However we did not see changes in the activation marker CD86.
There is need to analyse other markers, such as B7-H1, B7-H2, lg-like
transcripts 3 and 4 which might play a role in the function of
tolerogenic DCs [77–81], particularly in younger age groups.
Functional studies, will be very informative and will clarify some
of these areas, but were beyond the scope of this study.
In summary this study clearly shows there is an age-related
pattern in the proportions mDCs in people exposed to S.
haematobium infection as is typical for many already investigated
humoral and cellular responses. Furthermore, in the case of
mDCs, this pattern differs between schistosome infected and un-
infected people and also follows the age profile with infection of
protective responses, which is supported by the correlation
between schistosome-specific IgG and proportions of mDCs.
The mechanism and consequences (such as alterations in the
potential to induce different T cell phenotypes) behind the
association between mDCs and infection remain to be determined.
Understanding the nature and dynamics of immunological
parameters in natural helminth infections and, in particular,
changes of DCs involved in polarising the immune responses has
an important impact on the development of vaccines against
schistosomes.
Supporting Information
Figure S1 Proportions of mDCs and pDCs expressed as
percentage of CD14neg-HLA-DR+ cells. The study popula-
tion was divided into three age groups: 5–9 years (A), 10–13 years
(B) and 14+ years (C). Proportions of mDCs (A) or pDC (B) were
compared between un-infected (white box) and infected (gray box)
individuals and expressed as % percentage of CD14neg-HLA-
DR+. Differences between un-infected and infected groups in the
different age groups were analysed by univariate analysis after
accounting for the effect of sex.
(TIF)
Table S1 Interaction between WWH-IgE and mDC or
pDC.
(TIF)
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